As the first journal in the rapidly evolving field of bioelectronic medicine, we are committed to furthering the discovery and development of nerve stimulating and sensing technologies, changing the way we treat disease. Edited by renowned specialists, Bioelectronic Medicine unites material science, biochemistry, biophysics, molecular medicine, neuroscience, immunology, bioengineering, electrical engineering, mechanical engineering, computer science, mathematics, artificial intelligence, and other basic and clinical disciplines, bringing together clinicians and researchers from a diverse range of specialisms. Bioelectronic Medicine promises to bring new insights into the diagnosis and treatment of various diseases and conditions.
About Feinstein Institutes for Medical Research
Bioelectronic Medicine is published in partnership with The Feinstein Institutes for Medical Research. As the research arm of Northwell Health, the largest healthcare provider in New York, it is home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities. The Feinstein Institutes include 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how the Feinstein Institutes empower imagination and pioneers discovery, visit FeinsteinInstitute.org.
Update
We welcome pre-submission inquiries to help determine if your manuscript fits within Bioelectronic Medicine’s aims and scope, an email can be sent to: camille.donaghey@springernature.com. Please include a short overview of your submission and its re…
Update
Bioelectronic Medicine (BEM) combines molecular medicine, neuroscience, and biomedical engineering to treat disease with device-based therapies. The BEM Summit is an international meeting that brings together leaders across academia, medicine, and industry to discuss…
The Feinstein Institutes and Bioelectronic Medicine presented the 2024 Cerami Award to Seth Hays, PhD, Robert Rennaker, PhD, and Michael Kilgard, PhD, from University of Texas at Dallas. More information on the Cerami Award can be found here.
We are pleased to announce Bioelectronic Medicine is now indexed in the Emerging Sources Citation Index as part of the world’s most trusted citation index – the Web of Science Core Collection.
The FDA has approved SetPoint Medical's bioelectronic medicine device as a treatment for rheumatoid arthritis. This novel neuroimmunomodulation therapy targets the vagus nerve and is based on the pioneering scientific work of Dr. Kevin J. Tracey, our Editor-in-Chief. Read more here: FDA approves first vagus nerve device to treat rheumatoid arthritis | Northwell Health; New York Times Article.
Bioelectronic Medicine would like to recognize the efforts of its exceptional peer reviewers, for their excellent service. The following individuals have exceeded expectations as far as acceptance rate, the number of completed reviews, and timeliness, for each of the listed three-month periods. The journal cannot succeed without its peer reviewers, and we thank the hard-working members of our network.
